miR-22 suppresses DNA ligase III addiction in multiple myeloma
Open Access
- 17 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 33 (2), 487-498
- https://doi.org/10.1038/s41375-018-0238-2
Abstract
Multiple myeloma (MM) is a hematologic malignancy characterized by high genomic instability. Here we provide evidence that hyper-activation of DNA ligase III (LIG3) is crucial for genomic instability and survival of MM cells. LIG3 mRNA expression in MM patients correlates with shorter survival and even increases with more advanced stage of disease. Knockdown of LIG3 impairs MM cells viability in vitro and in vivo, suggesting that neoplastic plasmacells are dependent on LIG3-driven repair. To investigate the mechanisms involved in LIG3 expression, we investigated the post-transcriptional regulation. We identified miR-22-3p as effective negative regulator of LIG3 in MM. Enforced expression of miR-22 in MM cells downregulated LIG3 protein, which in turn increased DNA damage inhibiting in vitro and in vivo cell growth. Taken together, our findings demonstrate that myeloma cells are addicted to LIG3, which can be effectively inhibited by miR-22, promoting a novel axis of genome stability regulation.Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) (9980, 16695, 9980, 16695, 9980, 16695, 9980, 16695, 9980, 16695, 9980, 16695, 9980, 16695, 9980, 16695, 9980, 16695, 9980, 16722, 9980, 16695, 9980, 16695, 9980, 16722, 9980, 16695, 9980, 16695)
This publication has 62 references indexed in Scilit:
- miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1Cell Death & Disease, 2012
- Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma:In VitroandIn VivoEvidenceClinical Cancer Research, 2012
- Targeting Abnormal DNA Repair in Therapy-Resistant Breast CancersMolecular Cancer Research, 2012
- Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repairNature, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- RETRACTED: Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma DevelopmentCancer Cell, 2010
- Dysfunctional homologous recombination mediates genomic instability and progression in myelomaBlood, 2009
- Eukaryotic DNA Ligases: Structural and Functional InsightsAnnual Review of Biochemistry, 2008
- Widespread microRNA repression by Myc contributes to tumorigenesisNature Genetics, 2007
- The molecular classification of multiple myelomaBlood, 2006